Literature DB >> 20926588

NOD2 activation induces muscle cell-autonomous innate immune responses and insulin resistance.

Akhilesh K Tamrakar1, Jonathan D Schertzer, Tim T Chiu, Kevin P Foley, Philip J Bilan, Dana J Philpott, Amira Klip.   

Abstract

Insulin resistance is associated with chronic low-grade inflammation in vivo, largely mediated by activated innate immune cells. Cytokines and pathogen-derived ligands of surface toll-like receptors can directly cause insulin resistance in muscle cells. However, it is not known if intracellular pathogen sensors can, on their own, provoke insulin resistance. Here, we show that the cytosolic pattern recognition receptors nucleotide-binding oligomerization domain-containing protein (NOD)1 and NOD2 are expressed in immune and metabolic tissues and hypothesize that their activation in muscle cells would result in cell-autonomous responses leading to insulin resistance. Bacterial peptidoglycan motifs that selectively activate NOD2 were directly administered to L6- GLUT4myc myotubes in culture. Within 3 h, insulin resistance arose, characterized by reductions in each insulin-stimulated glucose uptake, GLUT4 translocation, Akt Ser(473) phosphorylation, and insulin receptor substrate 1 tyrosine phosphorylation. Muscle cell-autonomous responses to NOD2 ligand included activation of the stress/inflammation markers c-Jun N-terminal kinase, ERK1/2, p38 MAPK, degradation of inhibitor of κBα, and production of proinflammatory cytokines. These results show that NOD2 alone is capable of acutely inducing insulin resistance within muscle cells, possibly by activating endogenous inflammatory signals and/or through cytokine production, curbing upstream insulin signals. NOD2 is hence a new inflammation target connected to insulin resistance, and this link occurs without the need of additional contributing cell types. This study provides supporting evidence for the integration of innate immune and metabolic responses through the involvement of NOD proteins and suggests the possible participation of cell autonomous immune responses in the development of insulin resistance in skeletal muscle, the major depot for postprandial glucose utilization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926588     DOI: 10.1210/en.2010-0437

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  34 in total

Review 1.  Is immunity a mechanism contributing to statin-induced diabetes?

Authors:  Brandyn D Henriksbo; Jonathan D Schertzer
Journal:  Adipocyte       Date:  2015-04-20       Impact factor: 4.534

Review 2.  NOD1: An Interface Between Innate Immunity and Insulin Resistance.

Authors:  Sydney L Rivers; Amira Klip; Adria Giacca
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

3.  Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes.

Authors:  Abhijit Shiny; Bhaskaran Regin; Venketesan Balachandar; Kuppan Gokulakrishnan; Viswanathan Mohan; Subash Babu; Muthuswamy Balasubramanyam
Journal:  Cytokine       Date:  2013-09-06       Impact factor: 3.861

Review 4.  Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health.

Authors:  Connie W Y Ha; Yan Y Lam; Andrew J Holmes
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

5.  Different Th17 immunity in gut, liver, and adipose tissues during obesity: the role of diet, genetics, and microbes.

Authors:  Joseph F Cavallari; Emmanuel Denou; Kevin P Foley; Waliul I Khan; Jonathan D Schertzer
Journal:  Gut Microbes       Date:  2016

Review 6.  Skeletal muscle inflammation and atrophy in heart failure.

Authors:  Kory J Lavine; Oscar L Sierra
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

7.  Resistin increases the expression of NOD2 in mouse monocytes.

Authors:  Yi Ren; Taomei Wan; Zhicai Zuo; Hengmin Cui; Xi Peng; Jing Fang; Junliang Deng; Yanchun Hu; Shuming Yu; Liuhong Shen; Xiaoping Ma; Ya Wang; Zhihua Ren
Journal:  Exp Ther Med       Date:  2017-03-30       Impact factor: 2.447

8.  KPNβ1 promotes palmitate-induced insulin resistance via NF-κB signaling in hepatocytes.

Authors:  Suxin Wang; Yun Zhao; Nana Xia; Wanlu Zhang; Zhuqi Tang; Cuifang Wang; Xiaohui Zhu; Shiwei Cui
Journal:  J Physiol Biochem       Date:  2015-10-09       Impact factor: 4.158

9.  High-intensity exercise training increases the diversity and metabolic capacity of the mouse distal gut microbiota during diet-induced obesity.

Authors:  Emmanuel Denou; Katarina Marcinko; Michael G Surette; Gregory R Steinberg; Jonathan D Schertzer
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-04-26       Impact factor: 4.310

Review 10.  Therapeutic targeting of NOD1 receptors.

Authors:  L Moreno; T Gatheral
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.